Clinical Trials

Omalizumab in atopic dermatitis

Safety of omalizumab treatment in children (greater than 4 years) with high serum IgE and severe atopic dermatitis and food allergy

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here